Accumulating evidence indicates that deregulated microglial Nox2 activity is a key mechanism in a variety of neurodegenerative diseases, such as Parkinson’s (57) and Alzheimer diseases (58). Here, CYBB is linked to early-onset autosomal dominant Alzheimer disease.